| 초록 |
Background: The effect of elevated alkaline phosphatase (ALP) and phosphorus on vascular outcomes has been reported in several subgroups of patients. However, the long-term effect of ALP and phosphorus on vascular outcomes in stroke patients remains unknown. In this study, the differential effect of alkaline phosphatase (ALP) and phosphorus on cardiovascular and cerebrovascular outcomes was investigated in stroke patients, emphasizing the role of impaired renal function.
Methods: We analyzed the data of 1820 stroke patients obtained from a prospectively collected stroke registry and investigated the association between ALP and phosphorus and vascular outcomes.
Results: In multivariable Cox’s proportional hazard models, ALP was independently associated with composite vascular events, mortality, any stroke, and hemorrhagic stroke, whereas phosphorus lost statistical significance after adjustment for confounders. In a subgroup analysis according to estimated glomerular filtration rate (eGFR), ALP showed a similar trend in the low eGFR and high eGFR groups. However, phosphorus showed a differential association with composite outcomes and mortality in the low eGFR group, and an interaction between eGFR and phosphorus was significant for composite outcomes. In a propensity score-matched cohort, the positive interaction between the eGFR group and phosphorus for predicting composite outcomes remained significant.
Conclusions: This study showed that ALP and phosphorus were predictors for vascular outcomes in stroke patients. However, the association was affected differentially by impaired renal function. In addition, ALP level was associated with increased risk of hemorrhagic stroke among stroke subtypes. |